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Abstract
Background: Breast cancer risk education enables women make informed decisions regarding
their options for screening and risk reduction. We aimed to determine whether patient education
regarding breast cancer risk using a bar graph, with or without a frequency format diagram,
improved the accuracy of risk perception.
Methods: We conducted a prospective, randomized trial among women at increased risk for
breast cancer. The main outcome measurement was patients' estimation of their breast cancer risk
before and after education with a bar graph (BG group) or bar graph plus a frequency format
diagram (BG+FF group), which was assessed by previsit and postvisit questionnaires.
Results: Of 150 women in the study, 74 were assigned to the BG group and 76 to the BG+FF
group. Overall, 72% of women overestimated their risk of breast cancer. The improvement in
accuracy of risk perception from the previsit to the postvisit questionnaire (BG group, 19% to 61%;
BG+FF group, 13% to 67%) was not significantly different between the 2 groups (P = .10). Among
women who inaccurately perceived very high risk (≥ 50% risk), inaccurate risk perception
decreased significantly in the BG+FF group (22% to 3%) compared with the BG group (28% to 19%)
(P = .004).
Conclusion: Breast cancer risk communication using a bar graph plus a frequency format diagram
can improve the short-term accuracy of risk perception among women perceiving inaccurately high
risk.
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A patient's knowledge of risks and benefits is crucial to
informed decision making [1]. A woman's understanding
of her breast cancer risk is, therefore, potentially impor-
tant in her choice of breast cancer screening options or
risk-reduction strategies. The ability to clearly and accu-
rately convey the estimate of breast cancer risk is a vital
component of patient education that can enable a woman
to make an informed decision. Previous studies have
shown that women tend to overestimate their risk of
breast cancer [2,3]. To decrease such misinterpretations of
risk, it is imperative that women be presented information
regarding their estimated risk of breast cancer in an under-
standable format tailored to their level of understanding.
In a report on risk communication, Lipkus and Hollands
[4] showed that visual displays enhance the understand-
ing of numerical risk. Furthermore, in a qualitative study
using focus groups, women preferred a frequency format
diagram to probability estimates for communicating risk
estimates [5]. A review of the literature addressing the effi-
cacy of breast cancer risk communication showed that, of
several modalities used to communicate risk, no single
modality was the most efficacious [6]. In a study assessing
which formats are most accurately perceived by patients,
Feldman-Stewart et al [7] reported that, for making a
choice, systematic ovals, bars (horizontal or vertical), and
numbers were equally well perceived, whereas for estimat-
ing magnitude of risk, numbers led to the most accurate
estimates. Bogardus and colleagues [1] emphasized the
importance of research for ascertaining the best tech-
niques to communicate risks in the clinical setting.
Although several studies have analyzed risk communica-
tion, few have been randomized trials [2], and none, to
our knowledge, have been randomized trials comparing
the efficacy of specific formats of communicating risk
among women at high risk for breast cancer.
We conducted a prospective, randomized trial to compare
communication of breast cancer risk using a bar graph
(standard of care) versus the bar graph in addition to a fre-
quency format diagram (using highlighted human fig-
ures) among women at increased risk of breast cancer. The
aim of this study was to determine whether patient educa-
tion regarding breast cancer risk using a bar graph alone or
with the addition of a frequency format diagram
improved the accuracy of risk perception and to assess
women's preference for risk information provided as a bar
graph versus in a frequency format.
Methods
Study population
In 2005, women aged 40 years or older presenting to the
Breast Diagnostic Clinic at Mayo Clinic, Rochester, Min-
nesota, and considered to be at "increased breast cancer
risk" (defined below) were eligible for the study. They
were approached by the study coordinator to determine
their interest in participation in the study and were pro-
vided detailed information regarding the study; interested
persons provided informed consent. Women with prior
breast cancer or lobular carcinoma in situ, receiving che-
moprevention therapy (with tamoxifen, raloxifene, or in a
chemoprevention trial), or with a history of prophylactic
mastectomy were excluded. The study was approved by
the Mayo Clinic Institutional Review Board.
Definitions
Increased risk
Women were considered at "increased risk" 1) if the Gail
model risk estimate was greater than 1.66% for develop-
ment of invasive breast cancer over the next 5 years, 2) if
a breast biopsy showed atypical hyperplasia, 3) if at least
1 first-degree relative had breast cancer, or 4) if more than
2 second-degree relatives had breast cancer or ovarian can-
cer [8,9].
Previsit questionnaire
All participants completed a previsit questionnaire imme-
diately preceding the visit, providing information on edu-
cational status, Gail model risk factors, and current plans
for screening or risk reduction. Participants' own percep-
tion of their breast cancer risk was assessed as a 5-year esti-
mated risk of invasive breast cancer using numerical
values (< 2%, 2%–9%, 10%–49%, 50%–74%, or ≥ 75%).
Randomization
The standard of care in our practice has been to use a bar
graph to communicate breast cancer risk estimates.
Hence, all participants received a bar graph. Subjects were
first stratified by age (40–59 years ["younger"] and ≥ 60
years ["older"]); within each age group, subjects then were
randomly assigned to 1 of 2 groups: one to receive a bar
graph alone (BG group) and the other to receive both a
bar graph and a frequency format diagram (BG+FF group)
(Figure 1). A stratified and dynamic randomization tech-
nique was used [10].
Bar graph and frequency format diagram
Each patient's 5-year risk estimate of invasive breast can-
cer was calculated using the Gail model [8]. Each patient
in the BG group received a personalized bar graph (prob-
ability format) illustrating her 5-year risk estimate (Figure
2). Each participant assigned to the BG+FF group received
a bar graph as noted above, as well as a frequency format
diagram that pictorially showed consecutively highlighted
human figures to indicate the 5-year risk of invasive breast
cancer (Figure 2). A breast clinic medical provider dis-
cussed the patient's breast cancer risk estimate using the
format or formats described above and addressed breast
cancer risk-reduction strategies with the patient.Page 2 of 8
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Immediately after the visit with the breast clinic medical
provider (including risk counseling), each participant
completed a postvisit questionnaire before leaving the
breast clinic. The questionnaire assessed the patient's
breast cancer risk perception (5-year estimated risk of
breast cancer using numerical values), preference for the
bar graph or the frequency format diagram (for women in
the BG+FF group), plans for future breast cancer screening
options and risk-reduction strategies, and satisfaction
with the information provided during the counseling
visit. Our report focuses on risk perception and format
preference only.
Statistical analyses
The demographic characteristics of the study participants
were calculated as frequencies (percentages) or mean ± SD
and were compared between the 2 groups using the Pear-
son χ2 test or 2-sample t test, respectively. "Accurate risk
perception" was defined as the participant's perceived risk
estimate category matching her actual Gail model risk esti-
mate category. Intention-to-treat analysis was used such
that if a participant did not complete the postvisit ques-
tionnaire, the postvisit risk score was assigned the same
score as the previsit score. The accuracy of risk perception
was compared between the 2 groups using the Pearson χ2
test or logistic regression analysis to adjust for other fac-
tors. The difference in risk perception scores between the
previsit and postvisit questionnaires was analyzed using
the Wilcoxon rank sum test. The signed rank test was used
to detect whether the risk score improved within each
group. All P values less than .05 were considered statisti-
cally significant.
Flow of the patients through the studyigure 1
Flow of the patients through the study. BG group, received bar graph only; BG+FF group, received bar graph plus a fre-
quency format diagram.Page 3 of 8
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Of the 154 subjects who expressed an interest in the study,
150 provided informed consent and completed the pre-
visit questionnaire; 74 patients (34 younger, 40 older)
were randomly assigned to the BG group and 76 to the
BG+FF group (36 younger, 40 older) (Figure 1). Four par-
ticipants did not complete the postvisit questionnaire; all
of them were in the BG group and were included in the
study analyses (as detailed in the Methods).
Participants' demographic characteristics are shown in
Table 1. Mean ± SD age of the study participants was 60.2
± 10 years (range, 41–83 years). Most subjects were white
(88%), had at least a high school education (97%), and
had at least some college education (70%). No significant
differences were observed between the 2 groups with
regard to education, Gail model 5-year risk of invasive
breast cancer, family history of breast cancer, number of
prior breast biopsies, use of hormone replacement ther-
apy, menopausal status, or previsit risk perception (Table
1).
The Gail model 5-year risk of invasive breast cancer was
between 2% and 9% for 81% of the overall cohort; 17%
had a risk score of < 2%, and 2% of the sample had a score
of 10% to 49% (Table 1). On the previsit questionnaire,
72% of the overall cohort overestimated their risk of
breast cancer.
In the overall assessment of risk perception, accurate risk
perception was noted for 14 women (4 younger, 10 older;
19%) in the BG group before the visit and improved to 45
women (21 younger, 24 older; 61%) after the visit,
whereas in the BG+FF group, the accuracy of risk percep-
tion improved from 10 women (6 younger, 4 older; 13%)
before the visit to 51 women (26 younger, 25 older; 67%)
after the visit. The previsit to postvisit changes in accurate
risk perception are detailed in Figure 3. Of the 15 women
in the BG group with risk score < 2%, 3 (20%) had accu-
rate risk perception before the visit; this increased to 8
patients (53%) after the visit. For the 11 women in the
BG+FF group with risk score < 2%, accurate risk percep-
tion increased from 1 patient (9%) previsit to 6 patients
(55%) postvisit. The overall difference in level of
Two methods of communicating riskFigure 2
Two methods of communicating risk. The bar graph and frequency format diagram depict a 20% 5-year estimated Gail 
model risk of invasive breast cancer in a hypothetical patient X.Page 4 of 8
(page number not for citation purposes)
BMC Women's Health 2008, 8:18 http://www.biomedcentral.com/1472-6874/8/18
Page 5 of 8
(page number not for citation purposes)
Table 1: Demographics of the study population
Variable BG group* (n = 74) BG+FF group* (n = 76) P value†
Mean ± SD Age, years 60.9 ± 9.8 59.6 ± 10.2 .44‡
Education .32
Elementary 4 (5%) 0 (0%)
High school 21 (28%) 20 (26%)
Some college 21 (28%) 25 (33%)
College graduate 11 (15%) 14 (18%)
Graduate or professional degree 17 (23%) 17 (22%)
Mean ± SD Gail risk score 3.7 ± 2.1 3.2 ± 1.7 .12‡
Gail risk score categories .51
< 2% 15 (20%) 11 (14%)
2%–9% 57 (77%) 64 (84%)
10%–49% 2 (3%) 1 (1%)
≥ 50% 0 (0%) 0 (0%)
Family history .28
No 14 (19%) 20 (26%)
Yes 60 (81%) 56 (74%)
Prior biopsy .24
None 36 (49%) 25 (33%)
1 20 (27%) 25 (33%)
2 12 (16%) 19 (25%)
≥ 3 6 (8%) 7 (9%)
HRT use > .99
Never used 35 (47%) 36 (47%)
Used 38 (51%) 39 (51%)
Unknown 1 (1%) 1 (1%)
Menopause .14
No 13 (18%) 21 (28%)
Yes 61 (82%) 55 (72%)
HRT, hormone replacement therapy.
*Values are number of subjects (%) unless otherwise stated.
†Pearson χ2 test.
‡Using 2-sample t test.
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significant (P = .10 by the Pearson χ2 test and P = .29 by
logistic regression when previsit score and age were in the
model); age also did not affect the scores (P = .57).
The results of the previsit and postvisit questionnaires,
depicting patients' self-reported estimates of their risk
compared with the actual Gail risk model results, are
shown in Table 2. Although 121 (81%) of the overall
group had a Gail risk score of 2% to 9%, only 15 women
(20%) in the BG group and 13 women (17%) in the
BG+FF group estimated this risk on the previsit question-
naire, with 11 and 9 women, respectively, giving accurate
responses (Figure 3). However, on the postvisit question-
naire, 40 women (54%) in the BG group and 47 (62%) in
the BG+FF group estimated this level of risk, which was an
accurate risk estimation for 36 and 44 women, respec-
tively. This increase constituted an improvement in risk
estimation for both groups, but the difference between
groups was not significant (P = .17).
Although none of the women in the study had Gail model
risk estimates of 50% or greater, 21 women (28%) in the
BG group and 17 (22%) in the BG+FF group reported
such high risk on the previsit questionnaire (Table 2). Of
interest, after risk education, 14 women (19%) in the BG
group still reported risk of 50% or higher, whereas only 2
women (3%) in the BG+FF group reported this high level
of risk (P = .004). The difference between previsit and
postvisit perception of high risk was greater in the BG+FF
group (88% decrease) than in the BG group (33%
decrease) (P < .001).
In response to the question assessing preference for pres-
entation of risk information, asked only of women who
saw both formats (BG+FF group), 34% (n = 26) "preferred
frequency format," 15% (n = 11) "preferred bar graph,"
43% (n = 33) felt that "both were just as good," and 8%
(n = 6) had "no preference/don't know."
Discussion
Understanding breast cancer risk is a vital component of
informed and participatory decision making [1,11]. Accu-
rate understanding of risk could potentially affect adher-
ence to recommendations for breast cancer screening,
evaluations for breast cancer diagnosis, selection of treat-
ment options for breast cancer, and strategies to decrease
the risk of breast cancer in women at high risk. Breast can-
cer risk estimates must, therefore, be communicated to
women in a manner that is easily understandable. This
study suggests that the use of a frequency format diagram
in addition to a bar graph to communicate breast cancer
risk can provide added benefit, especially for women who
inaccurately perceive very high risk.
Combining visual displays with numerical and written
information can be effective in communicating risk infor-
mation [12]. In our study, accurate risk perception for the
overall study population was reported by 16% of all par-
ticipants before the visit, whereas after risk communica-
tion using pictorial depiction of risk and verbal
communication, 64% of participants reported accurate
risk. Although risk perception improved after the visit
with the medical provider, there is still need for further
improvement, and these findings support the need for
continued research to enhance the risk communication
process. These findings also are comparable to previous
reports of women receiving breast cancer risk information
that showed short-term improvement in the accuracy of
risk perception after an educational visit [13,14]. Lipkus et
al [14] also reported that presenting risk as a point esti-
mate or as a range of risks decreased women's estimates of
their risks, but the women continued to overestimate their
risk relative to their Gail model risk scores.
In our study, no significant difference was noted in the
accuracy of risk perception between the BG group and the
BG+FF group (P = .10). Among women in the 2% to 9%
risk category, discussion using either the bar graph alone
or the bar graph plus the frequency format diagram
improved the accuracy of risk perception, but the differ-
ence between the groups was not statistically significant.
In contrast, among women who inaccurately perceived
very high risk (≥ 50%), the BG+FF group had significantly
Proportion of subjects providing accurate previsit and postvisit estimates of breast cancer riskFigure 3
Proportion of subjects providing accurate previsit 
and postvisit estimates of breast cancer risk. Subjects 
are stratified by group (BG or BG+FF) and their actual Gail 
model level of risk. Bars reflect the percentage of accurate 
previsit and postvisit estimates of risk based on the number 
of women accurately estimating that level of risk (numbers 
above bars) and the number of women in each risk category 
(numbers below bars).Page 6 of 8
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BG group (P = .004). In a previous report, Gigerenzer [15]
stated that Bayesian computations are easier when the
information is in a frequency format rather than in a prob-
ability format. Timmermans et al [11] used different for-
mats for communicating surgical risk to investigate the
effect of format on participants' interpretation of risk and
choice of treatment; they reported that vertical bars were
the most difficult to comprehend, whereas information in
the form of icons was most helpful for making a decision.
A frequency format diagram in addition to a bar graph for
depiction of a risk estimate may, therefore, improve the
accuracy of risk perception by highlighting or clarifying
low-risk status, especially among women inaccurately per-
ceiving high risk.
In a study of the effect of graphic format on perception of
risk magnitude, Schapira et al [16] reported that numeri-
cal lifetime risk was perceived to be of lower magnitude
when the subject was presented with a bar graph com-
pared with a pictorial display. They suggested that an
affective (emotional) response, resulting from identifica-
tion with the numerator of the risk estimate, may explain
their findings. Their study also reported that risk was per-
ceived to be of lower magnitude when symbols in the fre-
quency format diagram were highlighted consecutively
rather than randomly. In the current study, we highlighted
the human figures consecutively and found an enhanced
understanding of lower risk in the BG+FF group. An inter-
esting area for future research would be to assess whether
the size and characteristics of the display (eg, consecutive
highlighting), rather than the magnitude of risk itself,
affect risk perception.
In a study of risk communication among medical inpa-
tients aged 75 years and older, Fuller et al [17] found that
pictorial representation of probability with human figures
was better understood than simple verbal statements. A
subsequent report studying a younger population of inpa-
tients showed that patients of all ages have the potential
to misinterpret numerical probability information and
that pictorial description of risk was well understood by
all patients; the authors advocated the use of such tools in
clinical practice to communicate risk [18]. In the current
report, we found that age had no effect on the accuracy of
risk perception.
Previous studies of breast cancer risk perception found
that women tend to overestimate their risk [2,3]. In this
study, 72% of women overestimated their risk on the pre-
visit questionnaire. Even after intervention, 31% still over-
estimated their risk, which was not influenced by age,
education, family history, or use of hormone replacement
therapy. This finding highlights the need to objectively
evaluate additional strategies to enhance the understand-
ing of breast cancer risk.
The question of preference for format was addressed in
the BG+FF group. One-third of these participants pre-
ferred the frequency format diagram, and 43% believed
that it was just as good as the bar graph. Gigerenzer and
Edwards [19] reported that frequency statements foster
insight and decrease confusion when discussing single-
event probabilities. In another study, Schapira et al [16]
reported that a pictorial display was preferred to a bar
graph for presentation of single risks. Participants in that
study preferred consecutive rather than random highlight-
ing of the symbols in the pictorial display. Therefore, it
may be reasonable to incorporate the frequency format
diagram into clinical practice for breast cancer risk com-
munication.
The strength of this study lies in the prospective, rand-
omized study design, which enabled assessment of differ-
ent formats for risk communication between 2
comparable groups of high-risk women. Women present-
ing to the breast clinic were participants in the study, and
these results can be generalized to similar groups of high-
Table 2: Patient-reported risk perception (previsit and postvisit) and actual Gail model risk score
BG group (n = 74) * BG+FF group (n = 76) *
Gail model risk category Actual Previsit Postvisit Actual Previsit Postvisit
< 2% 15 (20%) 12 (16%) 10 (14%) 11 (14%) 12 (16%) 12 (16%)
2%–9% 57 (77%) 15 (20%) 40 (54%) 64 (84%) 13 (17%) 47 (62%)
10%–49% 2 (3%) 26 (35%) 10 (14%) 1 (1%) 34 (45%) 15 (20%)
50%–74% 0 14 (19%) 10 (14%) 0 16 (21%) 2 (3%)
≥ 75% 0 7 (9%) 4 (5%) 0 1 (1%) 0
*Values are number of subjects (%) in each category of breast cancer risk.Page 7 of 8
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has some limitations. The participant population was
mainly white and had at least a high school education,
which suggests that results may not be generalizable to all
populations. In addition, numeracy could have affected
understanding but was not addressed in this study and
may have provided further insight into the study findings.
Furthermore, we could not assess or control for the pro-
viders' oral explanations of breast cancer risk that could
potentially have contributed to allocation bias, but pro-
viders were advised to use only the format or formats of
communicating risk assigned to them for this study. Addi-
tional research is needed to assess retention of informa-
tion over time because this study only assessed risk
perception immediately after the visit.
Conclusion
In summary, this study showed that breast cancer risk
communication using a bar graph along with a frequency
format diagram can improve the accuracy of risk percep-
tion, especially among women perceiving inaccurately
high risk. Many women may prefer the frequency format,
suggesting that incorporating both of these formats into
clinical practice to communicate breast cancer risk is rea-
sonable. Future studies to include larger populations of
women with varying risk and educational status, and
longer-term follow-up of the participants to assess sus-
tained understanding of risk, are indicated in our efforts
to enhance risk communication.
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